ABLACARE
AblaCare develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide patients with a more natural and less medicalised pregnancy experience. AblaCare aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. AblaCare's procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
ABLACARE
Industry:
Health Care Medical Device
Founded:
2017-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.ablacare.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Apache
Similar Organizations
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series A - AblaCare
MedTech Innovator
MedTech Innovator investment in Seed Round - AblaCare
Official Site Inspections
http://www.ablacare.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
